Astrocytes in Parkinson Disease

Parkinson's disease (PD) is a neurodegenerative disorder caused by the progressive loss of dopaminergic neurons. Some PD-genes may be associated with astrocyte dysfunction. Discover the latest research on astrocytes in Parkinson's disease here.

November 13, 2020
Open Access

The Function of Astrocyte Mediated Extracellular Vesicles in Central Nervous System Diseases

Frontiers in Cell and Developmental Biology
Tahereh GharbiGuo-Yuan Yang
December 16, 2020
Open Access

TLR7/8 in the Pathogenesis of Parkinson's Disease

International Journal of Molecular Sciences
Michela CampoloIrene Paterniti
January 25, 2021
Open Access

Validation of the new pathology staging system for progressive supranuclear palsy

MedRxiv : the Preprint Server for Health Sciences
M. BriggsSanne S Kaalund
December 1, 2020
Open Access

Cytoprotective and Neurotrophic Effects of Octadecaneuropeptide (ODN) in in vitro and in vivo Models of Neurodegenerative Diseases

Frontiers in Endocrinology
Olfa Masmoudi-KoukiDavid Vaudry
December 10, 2020
Open Access

Copper Dyshomeostasis in Neurodegenerative Diseases-Therapeutic Implications

International Journal of Molecular Sciences
Grażyna GromadzkaAgata Adamczyk
November 27, 2020
Open Access

Biomaterial based strategies to reconstruct the nigrostriatal pathway in organotypic slice co-cultures

Acta Biomaterialia
Buket UcarChristian Humpel
January 24, 2021

α-Synuclein Oligomers Induce Glutamate Release from Astrocytes and Excessive Extrasynaptic NMDAR Activity in Neurons, Thus Contributing to Synapse Loss.

The Journal of Neuroscience : the Official Journal of the Society for Neuroscience
Dorit TrudlerStuart A Lipton
January 18, 2021

Inflammation and Parkinson's disease pathogenesis: Mechanisms and therapeutic insight

Progress in Molecular Biology and Translational Science
Gianluigi ForloniClaudia Balducci
January 14, 2021

Targeting PTB as a One-Step Procedure for In Situ Astrocyte-to-Dopamine Neuron Reprogramming in Parkinson's Disease

Neuroscience Bulletin
Yuanyuan JiangZhihui Huang
January 11, 2021
Open Access

The impact of dextran sodium sulphate and probiotic pre-treatment in a murine model of Parkinson's disease

Journal of Neuroinflammation
Zach DwyerShawn Hayley
December 15, 2020
Open Access

Ageing and MPTP- sensitivity depend on molecular and ultrastructural signatures of astroglia and microglia in mice nigra

BioRxiv : the Preprint Server for Biology
P. AbhilashPhalguni Anand Alladi
November 20, 2020
Open Access

Locus Coeruleus Modulates Neuroinflammation in Parkinsonism and Dementia

International Journal of Molecular Sciences
Filippo Sean GiorgiFrancesco Fornai
January 23, 2021

GDNF Receptor Agonist Alleviates Motor Imbalance in Unilateral 6-Hydroxydopamine Model of Parkinson's Disease.

Frontiers in Neurology and Neuroscience Research
Juho-Matti RenkoRaimo K Tuominen
December 22, 2020

Tauroursodeoxycholic acid (TUDCA) is neuroprotective in a chronic mouse model of Parkinson's disease

Nutritional Neuroscience
Elvis CuevasSumit Sarkar
November 24, 2020

Preferential microglial activation associated with pathological alpha synuclein transmission

Journal of Clinical Neuroscience : Official Journal of the Neurosurgical Society of Australasia
Young Eun KimBeomseok Jeon
January 15, 2021

Febuxostat Inhibits MPP+-Induced Inflammatory Response Through Inhibiting the JNK/NF-κB Pathway in Astrocytes

Neurotoxicity Research
Weiwei YanHongmei Zhou

Sign up to follow this feed and discover related papers.

Related Feeds

3D Cellular Models of Brain and Neurodegeneration

Brain organoids are three-dimensional in vitro cellular models of the brain that can recapitulate many processes such as the neurodevelopment. In addition, these organoids can be combined with other cell types, such as neurons and astrocytes to study their interactions in assembloids. Disease processes can also be modeled by induced pluripotent stem cell-derived organoids and assembloids from patients with neurodegenerative disorders. Discover the latest research on the models here.


TAR DNA-binding protein 43 (TDP-43) is a pathological protein identified in sporadic Amyotrophic Lateral Sclerosis (ALS) and Frontotemporal Dementia (FTD). Here are the latest discoveries pertaining to TDP-43 and these diseases.

ALS: Genetics

Amyotrophic Lateral Sclerosis (ALS) is a progressive neurodegenerative disorder characterized by muscle weakness. ALS is a genetically heterogeneous disorder with several causative genes. Here are the latest discoveries pertaining to the genetics of this disease.

ALS: Pathogenic Mechanisms

Amyotrophic Lateral Sclerosis is a progressive neurodegenerative disorder characterized by muscle weakness. Here is the latest research investigating pathogenic mechanisms that underlie this genetically heterogeneous disorder.

ALS: Phenotypes

Amyotrophic Lateral Sclerosis (ALS) is a neurodegenerative disorder characterized phenotypically by progressive muscle weakness. Clinical phenotypes of ALS can be classified based on the pattern, level, and area of onset (e.g. bulbar, cervical, lumbar). Here is the latest research investigating phenotypes of ALS.

ALS: Prions

Prions are misfolded proteins which characterize several fatal neurodegenerative diseases. Prion-like mechanisms are associated with the pathogenesis of Amyotrophic Lateral Sclerosis (ALS). Here is the latest research on ALS and prions.

ALS: Stress Granules

Amyotrophic Lateral Sclerosis (ALS) is a neurodegenerative disease characterized by cytoplasmic protein aggregates within motor neurons. TDP-43 is an ALS-linked protein that is known to regulate splicing and storage of specific mRNAs into stress granules, which have been implicated in formation of ALS protein aggregates. Here is the latest research in this field.

ALS: Therapies

Amyotrophic Lateral Sclerosis (ALS) is associated with the death of neurons that control voluntary muscles. This feed followes the latest research into therapies for this progressive neurodegenerative disease.

Age-related Dementia

Dementias are a group of conditions, including Alzheimer's disease, vascular dementia, and frontotemporal dementia, characterized by deficiencies in cognitive abilities. Age-related dementia refers to dementias that occur in older individuals, usually 60+ years old, in contrast to early-onset dementia. Follow the latest research on age-related dementia here.

Alexander Disease

Alexander disease is a rare leukodystrophy caused by mutations in the astrocyte-specific intermediate filament protein glial fibrillary acidic protein (GFAP). Here is the latest research on this disease.

© 2021 Meta ULC. All rights reserved